Blood Podcast
The Blood Podcast summarizes content recently published in Blood, the most cited peer-reviewed publication in the field of hematology.
O podcaście
The Blood Podcast summarizes content recently published in Blood, the most cited peer-reviewed publication in the field of hematology.
359
Odcinki
English
Język
0
Subskrybenci
0
Odsłuchania
Odcinki25
Novel Treatment Targets for Hemophilia A and AML
Dec 25, 2025·—
—
Novel Differentiation Therapies for AML and Prognostic Value of PET in MM
Dec 18, 2025·—
—
Review Series on Platelet Heterogeneity
Dec 11, 2025·—
—
Special Episode: Maternal Health in Hematology
Dec 5, 2025·—
—
Analysis of IELSG37 Trial Results and PF4 in Stem Cell Aging
Dec 4, 2025·—
—
Fixed-Duration Epcoritamab Combination Therapy for Relapsed or Refractory Follicular Lymphoma and Pre-Transplant Strategies for GVHD post-HSCT
Nov 27, 2025·—
—
Advancing Blood Disorder Treatments Through Precision Therapeutics
Nov 20, 2025·—
—
New Research: Mitochondrial DNA in TRALI and Venetoclax-Obinituzumab in CLL Trials
Nov 13, 2025·—
—
Bispecific Antibodies in Aggressive B-Cell Lymphoma: Real-World Insights and Future Directions
Nov 6, 2025·—
—

Review Series on Follicular Lymphoma
Oct 30, 2025·—
—
Breakthroughs in Multiple Myeloma Treatment and Von Willebrand Disease Mechanisms
Oct 23, 2025·—
—

Spotlight on Acute Myeloid Leukemia
Oct 16, 2025·—
—
Busulfan-melphalan conditioning in newly diagnosed, transplant-eligible multiple myeloma; and use of spatial transcriptomics to probe the three-dimensional properties of multiple myeloma bone marrow microenvironments
Oct 14, 2025·—
—

How I Treat Wiskott-Alrich syndrome
Oct 2, 2025·—
—
Use of Marstacimab for Prophylaxis in hemophilia A and B; matched-donor allogeneic CD19 CAR-T in adult B-ALL; a new prognostic index for T-cell cutaneous lymphomas
Oct 2, 2025·—
—
Epstein-Barr virus genomic variants in human disease states, somatic GATA1 mutations and leukemia in Down syndrome, and new definitions for high-risk multiple myeloma
Sep 25, 2025·—
—

Review Series on Acute Lymphoblastic Leukemia (ALL)
Sep 18, 2025·—
—
Azacitidine holds promise in VEXAS syndrome; a step forward in precision blood matching; identifying a new vulnerability in TP53-mutated AML
Sep 18, 2025·—
—
Diffuse large B-cell lymphoma’s long-term effects on immune profiles, plasminogen activation and prevention of venous thromboembolism, and PARP inhibitors in hematological malignancies carrying epigenetic mutations
Sep 11, 2025·—
—
“Ironing out” Tet2-mutant HSPCs; A CAR-T “license to kill” in T cell leukemia/lymphoma; insights on cHL genetics, through the lens of ctDNA
Sep 4, 2025·—
—
Targeting NPM1 in AML with a menin inhibitor; in primates, a CD137 ADC eliminates acute GVHD
Aug 28, 2025·—
—

How I Treat Series on Iron Overload in Hematologic Disorders
Aug 28, 2025·—
—
Early prediction of follicular lymphoma patients with poor survival; immune hotspots in aplastic anemia; role of allo-transplant for Hodgkin lymphoma in the checkpoint inhibitor era
Aug 21, 2025·—
—
Exogenous CD19 stimulation in B-cell acute lymphoblastic leukemia treated with CD19 CAR T-cell therapy, sequential rapid immune-assay in heparin-induced thrombocytopenia diagnosis, and new survival prediction models for chronic myelomonocytic leukemia
Aug 19, 2025·—
—

How I Treat series on Acute Myeloid Leukemia
Aug 14, 2025·—
—


